These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 13199329)
1. Encephalitis in an infant after vaccination with 17 D yellow fever virus. SMITH JH Br Med J; 1954 Oct; 2(4892):852. PubMed ID: 13199329 [No Abstract] [Full Text] [Related]
2. Encephalitis in infants following vaccination with 17 D yellow fever virus: report of a further case. THOMPSON WO Br Med J; 1955 Jul; 2(4932):182-3. PubMed ID: 14389721 [No Abstract] [Full Text] [Related]
3. [Encephalitis in children in Costa Rica and Honduras after Dakar yellow fever vaccination]. EKLUND CM Bol Oficina Sanit Panam; 1953 Nov; 35(5):505-16. PubMed ID: 13105786 [No Abstract] [Full Text] [Related]
4. Encephalitis following neurotropic yellow fever vaccine administered by scarification in Nigeria: epidemiological and laboratory studies. STONES PB; MACNAMARA FN Trans R Soc Trop Med Hyg; 1955 Mar; 49(2):176-86. PubMed ID: 14373854 [No Abstract] [Full Text] [Related]
6. [Benign encephalitis after vaccination against yellow fever with a vaccine attenuated in embryonal tissue]. LARTIGAUT M; COUTEAU J Med Bord; 1954 May; 131(5):506-7. PubMed ID: 13184273 [No Abstract] [Full Text] [Related]
7. [Relevant vaccination for travellers]. Rieke B MMW Fortschr Med; 2003 Nov; 145(45):30-1. PubMed ID: 14699803 [No Abstract] [Full Text] [Related]
8. [Reactions to vaccination against yellow fever]. Pivetaud JP; Raccurt CP; M'Bailara L; Le Vigouroux A; Le Bras M Bull Soc Pathol Exot Filiales; 1986; 79(5 Pt 2):772-6. PubMed ID: 3829216 [TBL] [Abstract][Full Text] [Related]
11. Benefit versus risk factors in immunization against yellow fever. Brès P Dev Biol Stand; 1979; 43():297-304. PubMed ID: 574841 [No Abstract] [Full Text] [Related]
12. Japanese encephalitis virus/yellow fever virus chimera is safe and confers full protection against yellow fever virus in intracerebrally challenged mice. Yang H; Yang H; Li Z; Liu L; Wang W; He T; Fan F; Sun Y; Liu J; Li Y; Zeng X Vaccine; 2018 Apr; 36(18):2450-2455. PubMed ID: 29580643 [TBL] [Abstract][Full Text] [Related]
14. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005. Fernandes GC; Camacho LA; Sá Carvalho M; Batista M; de Almeida SM Vaccine; 2007 Apr; 25(16):3124-8. PubMed ID: 17316927 [TBL] [Abstract][Full Text] [Related]
16. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination. Adu FD; Adeniji JA; Tomori O; Adelasoye A Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476 [TBL] [Abstract][Full Text] [Related]
17. [Use of stabilized yellow fever vaccine 17D at the time of the yellow fever epidemic in Burkina Faso in 1983]. Saluzzo JF; Some L; Baudon D; Girault G; Lhuillier M; Kambire PA; Roux JF; Digoutte JP Bull Soc Pathol Exot Filiales; 1985; 78(4):536-40. PubMed ID: 4075474 [TBL] [Abstract][Full Text] [Related]
18. Vaccines and vaccination against yellow fever. WHO position paper -- June 2013. Wkly Epidemiol Rec; 2013 Jul; 88(27):269-83. PubMed ID: 23909008 [No Abstract] [Full Text] [Related]
20. [Relation between viremia and sero-antibodies to the anti-yellow fever vaccination of persons vaccinated with strain 17D-EP]. Santiago Actis A; Sa Fleitas MJ Rev Sanid Milit Argent; 1970; 69(1):51-63. PubMed ID: 5530987 [No Abstract] [Full Text] [Related] [Next] [New Search]